These findings provide new insights into the occurrence and progression of HCC and indicate that the circMTO1/miR-541-5p/ZIC1 axis may serve as a potential therapeutic target for the treatment of HCC. The gene discussed is ZIC1; the disease is hepatocellular carcinoma.